Cargando…

Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany

Detalles Bibliográficos
Autores principales:	Ayaz, N Aktay, Özen, S, Lainka, E, Taskiran, E, Duzova, A, Besbas, N, Bakkaloglu, A, Kallinich, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333980/ http://dx.doi.org/10.1186/1546-0096-6-S1-P179

Ejemplares similares

Does unity of Familial Mediterranean fever with juvenile idiopathic arthritis affect the outcome?
por: Topaloglu, R, et al.
Publicado: (2008)

Assessment of children presenting with rheumatic complaints to a tertiary center in Turkey: differences in an Eastern Mediterranean population
por: Bircan Cavkaytar, Ö, et al.
Publicado: (2008)

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
por: Gohar, F, et al.
Publicado: (2013)

A safe protocol for tuberculin test assessment in a country where BCG vaccination is mandatory
por: Ayaz, N Aktay, et al.
Publicado: (2008)

Behcet Disease: treatment of vascular involvement in children
por: Bilginer, Y, et al.
Publicado: (2008)

Features of enthesitis related arthritis in Turkish children
por: Akkus, K, et al.
Publicado: (2008)

Musculoskeletal sonography in juvenile systemic lupus erythematosus
por: Demirkaya, E, et al.
Publicado: (2008)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey
por: Sozeri, B, et al.
Publicado: (2015)

PW01-004 – The sequence analysis in E148Q homozygous patients
por: Topaloglu, R, et al.
Publicado: (2013)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

PReS-FINAL-2195: The comparison of the efficacy of once and twice daily dosage of colchicine in pediatric patients with Familial Mediterranean Fever
por: Polat, A, et al.
Publicado: (2013)

A case of chronic recurrent multifocal osteomyelýtýs successfully treated with etanercept
por: Aktay Ayaz, N, et al.
Publicado: (2008)

PReS-FINAL-2258: Final diagnoses of pediatric patients presenting with musculoskeletal symptoms in a center from the eastern Mediterranean
por: Cavkaytar, O, et al.
Publicado: (2013)

Investigation of the inflammatory cell migration process in familial Mediterranean fever
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

P02-020 - CAPS in Turkish children: treatment with ANTI IL1
por: Eroglu, FK Kara, et al.
Publicado: (2013)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

Familial Mediterranean Fever: Diagnosing as Early as 3 Months of Age
por: Keskindemirci, Gonca, et al.
Publicado: (2014)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

PReS-FINAL-2207: Results from a multicenter international registry of Familial Mediterranean Fever: validation of the new set of pediatric diagnostic criteria
por: Demirkaya, E, et al.
Publicado: (2013)

Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever
por: Cakan, Mustafa, et al.
Publicado: (2019)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015)

The Comparison of Pediatric Patients with Familial Mediterranean Fever Originated from Turkey and Crimea
por: Kostik, Mikhail, et al.
Publicado: (2022)

Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
por: Topaloglu, R, et al.
Publicado: (2015)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey
por: Kavrul Kayaalp, Gülsah, et al.
Publicado: (2021)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, A, et al.
Publicado: (2015)

PReS-FINAL-2226: Assessment of autonomic functions in children with Familial Mediterranean Fever by using heart rate variability measurements
por: Fidanci, K, et al.
Publicado: (2013)

P01-008 – FMF genotype-phenotype correlations in Germany
por: Jeske, M, et al.
Publicado: (2013)

MEFV gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
por: Karaaslan, Y, et al.
Publicado: (2015)

Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
por: Akin, Onur, et al.
Publicado: (2011)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Chronic granulomatous disease in an infant with sweet syndrome
por: Hanedan, S, et al.
Publicado: (2008)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hf7igim3mng6uecmcng3gkh1fi